Added to YB: 2017-03-21
Pitch date: 2017-03-21
MCRB:US [bullish]
Seres Therapeutics, Inc.
-95.72%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases.
Market Cap
$76.6M
Pitch Price
$204.40
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.41
P/E
13.68
EV/Sales
325.47
Sector
Biotechnology
Category
N/A
Show full summary:
SERES THERAPEUTICS INC COM MCRB:US
A summary for this pitch has not been created yet.
Read full article (0 min)